Literature DB >> 17056639

Rituximab in refractory antineutrophil cytoplasmic antibody-associated vasculitis: what is the current evidence?

Christopher F Wong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17056639     DOI： 10.1093/ndt/gfl573

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  8 in total

1.  Rituximab: a review of dermatological applications.

Authors:  Jason J Emer; Wolinsky Claire
Journal:  J Clin Aesthet Dermatol       Date:  2009-05

2.  Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.

Authors:  Achille Aouba; Christian Pagnoux; Boris Bienvenu; Alfred Mahr; Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2007-09-12       Impact factor: 8.667

Review 3.  Rituximab and minimal change nephrotic syndrome: a therapeutic option.

Authors:  Takashi Takei; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2011-05-26       Impact factor: 2.801

4.  [Necrotizing granulomatosis with pulmonary, intestinal and renal involvement].

Authors:  Jörg Steinbach; Peter Bartsch; Dorothea Langer; Hans-Peter Bosselmann; Klaus H Neumann; Peter R Mertens
Journal:  Med Klin (Munich)       Date:  2010-12-07

5.  Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Eugene P Rhee; Karen A Laliberte; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

Review 6.  The potential utility of B cell-directed biologic therapy in autoimmune diseases.

Authors:  D G Arkfeld
Journal:  Rheumatol Int       Date:  2007-10-24       Impact factor: 2.631

7.  Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series.

Authors:  Ryosuke Usui; Yohei Tsuchiya; Kosaku Nitta; Minako Koike
Journal:  Case Rep Nephrol Dial       Date:  2018-10-22

Review 8.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.